(Q52216151)

27 April 2018

title

Oral physostigmine and lecithin improve memory in Alzheimer disease (English)

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

4 October 2023

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

4 October 2023

author name string

L. J. Thal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347034

4 October 2023

P. A. Fuld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347034

4 October 2023

D. M. Masur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347034

4 October 2023

N. S. Sharpless

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6347034

4 October 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6347034

4 October 2023

publication date

1 May 1983

1 reference

27 April 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fana.410130504

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

https://onlinelibrary.wiley.com/doi/full/10.1002/ana.410130504

4 October 2023

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

4 October 2023

1 reference

27 April 2018

volume

13

1 reference

27 April 2018

page(s)

491-496

1 reference

27 April 2018

issue

5

1 reference

27 April 2018

Lecithin and memory training in suspected Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FANA.410130504

Evaluating storage, retention, and retrieval in disordered memory and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410130504

Human memory and the cholinergic system. A relationship to aging?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410130504

Effect of Physostigmine on Constructional and Memory Tasks in Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410130504

Memory Enhancement After Physostigmine Treatment in the Amnesic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FANA.410130504

Radioimmunoassay for GH-Release Inhibiting Hormone

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

4 October 2023

3

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Neurotransmitter-related enzymes in senile dementia of the alzheimer type

4 October 2023

8

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Selective loss of central cholinergic neurons in Alzheimer's disease

4 October 2023

9

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains

4 October 2023

10

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine

4 October 2023

12

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

The New England Journal of Medicine

4 October 2023

13

301

946

Davis

1979

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Release of vasoactive intestinal peptide in the central nervous system in man

4 October 2023

16

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Clinical effects of choline in Alzheimer's disease

4 October 2023

18

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Communications in psychopharmacology

4 October 2023

19

4

141

Fovall

1980

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Quantitative assay of physostigmine in human whole blood

4 October 2023

20

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Physostigmine in familial ataxias

4 October 2023

21

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Necropsy evidence of central cholinergic deficits in senile dementia

4 October 2023

24

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Effects of physostigmine and lecithin on memory in Alzheimer disease

4 October 2023

26

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

4 October 2023

27

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

The New England Journal of Medicine

4 October 2023

28

301

330

Renvoize

1979

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Acetylcholine and choline levels in post-mortem human brain tissue: preliminary observations in Alzheimer's disease.

4 October 2023

29

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Influence of choline on amnesia in early Alzheimer's disease

4 October 2023

32

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease.

4 October 2023

33

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Choline chloride fails to improve cognition in Alzheimer's disease

4 October 2023

34

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

Neocortical cholinergic neurons in elderly people

4 October 2023

35

1 reference

https://api.crossref.org/works/10.1002/ANA.410130504

4 October 2023

Identifiers

1 reference

27 April 2018

1 reference

27 April 2018